Skip to main content
. 2021 Jan;22(1):131–137. doi: 10.31557/APJCP.2021.22.1.131

Table 1.

Comparison between Serum Levels of Ca15-3 (U/ml) and CEA (ng/mL), Ca19-9 (U/ml) and CEA (ng/ml) and TSPA (U/ml) in Control, Breast, Colorectal and Prostate Cancer Patients

Control BC CRC PCa
Ca15-3 19.47 (13.38-24.07) 52.63 (35.28,130.8)***
CEA 1.57 (0.97-2.13) 15.6 (6.74-52.75)***
Ca19-9 5.77 (1.79-6.41) 19.37(9.18-46.16)***
CEA 1.105 (0.57-1.59) 3.1 (1.88-22)***
TPSA 1.26 (0.62-2.98) 64.01 (18.93-165.7)***

**, represents P value 0.01; ***, represents P value 0.001